Sarepta Therapeutics, Inc. (SRPT) has a market capitalization of $2.33B and trades at $22.15. The 52-week range is 10.42-64.8.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.1, Earnings Per Share (EPS) of $-7.13, annual revenue of $2.2B.
The stock has a beta of 0.28, operates in the Healthcare sector.
